Quantcast

Latest Complement system Stories

2015-04-14 08:28:58

-- Patients with Thrombotic Microangiopathy Will Now Be Able to Receive Extended Treatment - SEATTLE, April 14, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced

2015-02-19 08:33:29

- The Company Agrees to Physician Request to Continue Treatment of Patients with aHUS - SEATTLE, Feb.

2015-02-10 08:32:11

CRESTWOOD, Ky., Feb. 10, 2015 /PRNewswire/ -- Apellis Pharmaceuticals, Inc.

2014-11-20 04:22:18

CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.

2014-11-19 08:27:47

- Data Bode Well for Success of Ongoing Phase 2 Trial in Thrombotic Microangiopathies - SEATTLE, Nov.

2014-04-03 08:29:04

-- Phase 2 Clinical Trial Planned to Begin This Quarter -- SEATTLE, April 3, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug

2014-03-31 16:27:38

OAKLAND, Calif., March 31, 2014 /PRNewswire/ -- Machaon Diagnostics today announced the availability of its "aHUS Genetic Panel(TM)" (patent pending) to genetically confirm atypical Hemolytic

2014-03-26 11:32:37

A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies).

2014-03-10 08:29:22

- Phase 2 Clinical Trial in aHUS and Other TMAs Expected to Begin Next Quarter - SEATTLE, March 10, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'